AZ Sint-Jan Brugge — Bruges, West-Vlaanderen

Public research footprint of AZ Sint-Jan Brugge, compiled from the ClinicalTrials.gov public registry.

210

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus · Atrial Fibrillation · Ischemic Stroke · HER2-(Ultra)Low Expressing Breast Cancer

Recently updated registry entries

NCT07215273 — Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy (Recruiting)
NCT05878769 — A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… (Recruiting)
NCT05159492 — Ground-Breaking Electroporation-based Intervention for PAROXysmal Atrial Fibrillation… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at AZ Sint-Jan Brugge?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.